GlassScriptPhysician profile
Hyejin Kwon
NPI 1023501236
$5,851.59
in general payments reported to CMS, 2019-2025
11 companies · $3,088 in 2025
The $3,088 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $108 · 2021: $466 · 2022: $737 · 2023: $544 · 2024: $676 · 2025: $3,088.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,655 · Travel and Lodging: $1,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,654.58 |
| Travel and Lodging | $1,652.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,205.43 | 2025 | Inspiris Resilia Aortic Valve, Konect Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Atricure, INC. | $1,939.56 | 2021-2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System, Atriclip Laa Exclusion System |
| Abbott Laboratories | $778.94 | 2019-2024 | Mitraclip |
| Lsi Solutions INC | $195.92 | 2024-2025 | Cor-Knot |
| Ambu INC. | $154.88 | 2022 | |
| Abiomed | $147.04 | 2025 | |
| Corcym INC | $139.29 | 2023 | Perceval |
| Avanos Medical | $136.07 | 2021 | |
| Zimmer Biomet Holdings, INC. | $102.98 | 2019 | |
| Lemaitre Vascular, INC. | $33.23 | 2025 | Restoreflow |
| Solventum Corporation | $18.25 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hyejin Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.